M. Hamdan et al., A. (2022). Cytotoxicity and antimicrobial activities of the novel lactic acid bacterium, Lactobacillus brevis A13, isolated from the gut of the polychaete, Perinereis nuntia. Egyptian Journal of Aquatic Biology and Fisheries, 26(1), 533-547. doi: 10.21608/ejabf.2022.221762
Amira M. Hamdan et al.. "Cytotoxicity and antimicrobial activities of the novel lactic acid bacterium, Lactobacillus brevis A13, isolated from the gut of the polychaete, Perinereis nuntia". Egyptian Journal of Aquatic Biology and Fisheries, 26, 1, 2022, 533-547. doi: 10.21608/ejabf.2022.221762
M. Hamdan et al., A. (2022). 'Cytotoxicity and antimicrobial activities of the novel lactic acid bacterium, Lactobacillus brevis A13, isolated from the gut of the polychaete, Perinereis nuntia', Egyptian Journal of Aquatic Biology and Fisheries, 26(1), pp. 533-547. doi: 10.21608/ejabf.2022.221762
M. Hamdan et al., A. Cytotoxicity and antimicrobial activities of the novel lactic acid bacterium, Lactobacillus brevis A13, isolated from the gut of the polychaete, Perinereis nuntia. Egyptian Journal of Aquatic Biology and Fisheries, 2022; 26(1): 533-547. doi: 10.21608/ejabf.2022.221762
Cytotoxicity and antimicrobial activities of the novel lactic acid bacterium, Lactobacillus brevis A13, isolated from the gut of the polychaete, Perinereis nuntia
The present study was implemented to evaluate the cytotoxicity and antimicrobial activities of the novel lactic acid bacterium, Lactobacillus brevis A13, isolated from the gut of the polychaete worm, Perinereisnuntia. The results indicated that L. brevis A13 acquired a broad antimicrobial spectrum against the tested bacterial pathogens with multiple antibiotic resistance (MAR) index value of 0.57. Pure bacteriocin had a molecular weight of approximately 4.0 kDa and was designated as "Brevicin-13". Furthermore, brevicin-13 had a bactericidal nature, causing disruption and deformation of the cell membrane with cavities observed on the surface of Klebsiella pneumoniae ATCC 13883 cells. Compared to untreated cancer cells, brevicin-13 exhibited very strong cytotoxic activity, with inhibition rates of 93%, 95%, and 91% against three cancer cell lines; colon cancer (Caco-2), liver cancer (HepG2), and breast cancer (Mcf-7), respectively. The inhibition was clearly shown as anti-proliferative activity and detrimental effects of the cell nucleus due to the induction of apoptosis upon exposure to brevicin-13.